#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1344	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2617	119.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1684	1684	C	157	C,A	119,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1344	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2617	119.1	0	HET	.	.	.	C207T	.	207	207	C	707	707	C	128	C,T	79,27	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1344	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2617	119.1	0	HET	.	.	.	C451T,A	.	451	451	C	951	951	C	177	C,T,A	75,74,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2320	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3418	152.5	0	.	n	.	0	T695C	SNP	695	695	T	1003	1003	C	166	C	133	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2320	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3418	152.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2279	2279	C	178	C	147	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2320	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3418	152.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2353	2353	A	189	A	146	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2320	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3418	152.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2905	2905	C	149	C,T,A	116,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2320	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3418	152.5	0	HET	.	.	.	A1638G,C	.	1638	1638	A	1946	1946	A	190	A,G,C	117,42,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2320	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3418	152.5	0	HET	.	.	.	C1811T,A	.	1811	1811	C	2119	2119	C	182	C,T,A	70,82,2	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	148	folP	855	855	100.0	folP.l15.c4.ctg.1	1810	19.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1166	1168	AGC	21;21;21	A;G;C	16;17;16	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	346	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3750	22.0	1	SNP	p	S91F	1	.	.	271	273	TTC	877	879	TTC	24;24;24	T;T;C	18;19;19	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	346	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3750	22.0	1	SNP	p	G95N	0	.	.	283	285	GGC	889	891	GGC	25;25;25	G;G;C	20;20;20	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	346	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3750	22.0	1	SNP	p	D95G	1	.	.	283	285	GGC	889	891	GGC	25;25;25	G;G;C	20;20;20	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	160	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1756	21.8	1	SNP	p	G45D	0	.	.	133	135	GGC	690	692	GGC	38;38;38	G;G;C	32;29;33	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	94	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1318	17.1	0	.	n	.	0	A197.	DEL	197	197	A	733	733	A	37	A	32	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3424	29.7	1	SNP	p	D86N	0	.	.	256	258	GAC	897	899	GAC	37;37;38	G;A;C	28;25;29	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3424	29.7	1	SNP	p	R87W	0	.	.	259	261	CGT	900	902	CGT	39;39;39	C;G;T	34;28;32	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3424	29.7	1	SNP	p	R87I	0	.	.	259	261	CGT	900	902	CGT	39;39;39	C;G;T	34;28;32	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3424	29.7	1	SNP	p	S87R	1	.	.	259	261	CGT	900	902	CGT	39;39;39	C;G;T	34;28;32	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3424	29.7	1	SNP	p	S88P	0	.	.	262	264	TCC	903	905	TCC	39;39;39	T;C;C	32;32;33	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	364	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3285	26.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1829	1831	GGC	29;29;27	G;G,A;C,A	24;22,1;21,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1417	1419	GCC	36;36;36	G,T;C;C	31,1;32;32	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1420	1422	ATG	36;36;36	A;T;G,A	32;32;31,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1432	1434	ACC	36;36;36	A;C;C	32;32;32	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1432	1434	ACC	36;36;36	A;C;C	32;32;32	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1933	1935	ACC	24;24;24	A;C;C	21;20;22	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1987	1989	GCG	24;24;24	G;C;G	22;18;20	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1987	1989	GCG	24;24;24	G;C;G	22;18;20	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2110	2112	GGT	26;26;26	G;G,T;T	23;22,1;23	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2119	2121	AGC	25;26;26	A;G,A;C,A	19;21,1;19,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	306	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2595	27.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2137	2139	CCG	25;25;25	C,G;C,A;G,C,A	18,1;18,1;17,2,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	428	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3335	29.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1628	1630	CCG	29;29;29	C;C;G,T,C	25;25;21,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	216	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2155	24.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	581	581	C	26	C	18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	244	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	2183	27.1	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	708	710	CAG	40;40;40	C,T;A,T;G	35,1;35,1;36	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	244	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	2183	27.1	1	SNP	p	G120K	1	.	.	358	360	AAG	948	950	AAG	35;35;34	A;A;G,T	31;31;30,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	244	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	2183	27.1	1	SNP	p	A121N	1	.	.	361	363	AAC	951	953	AAC	34;34;34	A;A;C	31;31;31	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	244	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	2183	27.1	1	SNP	p	N121D	0	.	.	361	363	AAC	951	953	AAC	34;34;34	A;A;C	31;31;31	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	780	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5205	35.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	100	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1279	19.3	1	SNP	p	V57M	1	.	.	169	171	ATG	680	682	ATG	30;30;30	A;T;G	26;26;26	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
